Sarcopenic Obesity and Cardiovascular Disease: An Overlooked but High-Risk Syndrome

Shapiro, Michael D.

DOI: https://doi.org/10.1007/s13679-024-00571-2

2024-05-17

Current Obesity Reports

Abstract:Sarcopenic obesity (SO), defined as the coexistence of excess fat mass and reduced skeletal muscle mass and strength, has emerged as an important cardiovascular risk factor, particularly in older adults. This review summarizes recent findings on the diagnosis, prevalence, health impacts, and treatment of SO.

endocrinology & metabolism,nutrition & dietetics

What problem does this paper attempt to address?

The paper aims to explore the relationship between Sarcopenic Obesity (SO) and cardiovascular diseases, and summarizes the latest research findings on the diagnosis, prevalence, health impacts, and treatment of SO.

### Main Objectives
1. **Definition and Diagnostic Criteria**:
- Propose a unified diagnostic standard for SO to more accurately assess its prevalence and cardiometabolic risk.
- Discuss the consensus definition proposed by the European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO), which includes specific measurement methods for body fat percentage and skeletal muscle mass.

2. **Epidemiological Characteristics**:
- Analyze the prevalence of SO in different regions and age groups, pointing out that current estimates vary significantly due to the lack of a unified standard.
- The global prevalence of SO is 11%, but specific data vary significantly across regions, with higher prevalence rates in South America and North America.

3. **Health Impacts**:
- Explore the relationship between SO and the risk of cardiovascular metabolic diseases such as hypertension, dyslipidemia, diabetes, and metabolic syndrome.
- Point out the association between SO and various cardiovascular events (such as coronary heart disease, stroke, and other heart diseases) and related mortality.
- Emphasize the complex mechanisms between SO and cardiovascular diseases, including factors such as inflammation, oxidative stress, and mitochondrial dysfunction.

4. **Treatment Methods**:
- Summarize the main strategies for managing SO, including weight loss diets and resistance training.
- Mention that emerging pharmacological therapies show some potential but require further research for validation.

Through these discussions, the paper emphasizes the increasing importance of diagnosing and managing SO to alleviate the burden of cardiovascular diseases as the global population ages.